Leonurine: A new comer in the natural compounds affecting atherosclerosis

Atherosclerosis

Volumn 224, Issue 1, 2012, Pages 37-38

  Norata, Giuseppe Danilo ^a,b   Catapano, Alberico Luigi ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b Bassini Hospital   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

Drug interaction; Natural medicine; Natural substances

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; BERBERINE; CAFFEIC ACID; CHOLESTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEONURINE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RESVERATROL;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COPTIS CHINENSIS; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROENTERITIS; HUMAN; MONASCUS PURPUREUS; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS; GALLIC ACID; MALE;

EID: 84865354691     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.036     Document Type: Note

References (7)

1. Wei W., Li C., Wang Y., Su H., Zhu J., Kritchevsky D. Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. J Nutr Biochem 2003, 14(6):314-318.
2. Zhao S.P., Liu L., Cheng Y.C., et al. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation 2004, 110(8):915-920.
3. Kong W., Wei J., Abidi P., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004, 10:1344-1351.
4. Abidi P., Zhou Y., Jiang J.D., Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscl Thromb Vasc Biol 2005, 25:2170-2176.
5. Li K., Yao W., Zheng X., Liao K. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage. Cell Res 2009, 19(August (8)):1006-1017.
6. Norata G.D., Marchesi P., Passamonti S., Pirillo A., Violi F., Catapano A.L. Anti-inflammatory and anti-atherogenic effects of catechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007, 191:265-271.
7. Zhang Y., Guo W., Wen Y., et al. SCM-198 attenuates early atherosclerotic lesion in hypercholesterolemic rabbits via modulation of inflammation and oxidative stress pathways. Atherosclerosis 2012, 224(1):43-50.